355 filings
Page 8 of 18
424B5
58plc5d
8 Mar 18
Prospectus supplement for primary offering
12:00am
8-K
438249sr
1 Mar 18
VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update
12:00am
8-K
xy8ce5etbprimyda
9 Nov 17
VolitionRx Limited Announces Third Quarter 2017 Financial Results and Business Update
12:00am
S-8
si2sy6oatnq
20 Oct 17
Registration of securities for employees
12:00am
8-K
xdq05cad
21 Sep 17
VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding
12:00am
8-K
ggxmp0i5 670
12 Sep 17
Departure of Directors or Certain Officers
12:00am
8-K
tvo5 3zuagedlbe
9 Aug 17
VolitionRx Limited Announces Second Quarter 2017 Financial Results and Business Update
12:00am
8-K
criz2
19 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
weg64q1vx2b6s
16 May 17
VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update
12:00am
8-K
5n9f1bid6idbs 6b
12 Apr 17
VolitionRx Appoints David Vanston as Chief Financial Officer
12:00am
8-K
d6kabumi mo
16 Mar 17
VolitionRx Limited Announces Full Fiscal Year 2016 Financial Results and Business Update
12:00am
424B3
csfca l76aedl
13 Dec 16
Prospectus supplement
12:00am
8-K
o9665iv rtkmms
6 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
g72 v1ja963
15 Nov 16
VolitionRx Limited Announces Third Quarter 2016 Financial Results and Business Update
12:00am